IP Library Granted Patent US 10,632,306
Granted Patent B2
US 10,632,306 · App. 15/687,271 · Granted Apr 28, 2020

Obstructive sleep apnea treatment devices, systems and methods

Inventors: Stephen L. Bolea (Watertown, MN); Thomas B. Hoegh (Edina, MN); Brian D. Kuhnley (Maple Grove, MN); Dale G. Suilmann (Elk River, MN); Bruce J. Persson (Dresser, WI); John P. Beck (Prior Lake, MN); Sidney Hauschild (St. Paul, MN); Paula M. Kaplan (St. Paul, MN); Adam K. Hoyhtya (Shoreview, MN); Wondimeneh Tesfayesus (St. Paul, MN); Robert E. Atkinson (White Bear Lake, MN); Peter R. Eastwood (Floreat, AU); David R. Hillman (Nedlands, AU)
Assignee: LivaNova USA, Inc.
A61N1/3601A61B5/0538A61B5/4818A61N1/0556A61N1/3611A61N1/36139
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,632,306
App. No.
15/687,271
Granted
Apr 28, 2020
Kind
B2
Abstract

Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.

Claims (16)

1. An implantable neurostimulation system for delivering a respiratory therapy to a subject, comprising:

a neurostimulator adapted to deliver a neurostimulation signal to the subject, the neurostimulator comprising a microprocessor programmed to:

titrate a stimulation setting of the neurostimulator while the subject is awake by delivering a first set of stimulation pulses at a plurality of first stimulation setting values between a lower limit defined by a capture threshold corresponding to a beneficial effect of the respiratory therapy and a first upper limit defined by a comfort threshold corresponding to a negative sensation experienced by the subject; and

subsequently, when the subject is asleep, repeat the step of titrating the stimulation setting of the neurostimulator by delivering a second set of stimulation pulses at a plurality of second stimulation setting values, wherein one or more of the plurality of second stimulation setting values is different than one or more of the plurality of first stimulation setting values and the plurality of second stimulation setting values are between the lower limit defined by the capture threshold and a second upper limit defined by a threshold at which the patient is expected to at least partially arouse from sleep.

2. The neurostimulation system of claim 1 , wherein the awake titration includes determining a stimulation level that causes the subject discomfort.

3. The neurostimulation system of claim 2 , wherein the microprocessor is further programmed to, as part of the asleep titration, compare the subject's responses to the second and third sets of stimulation pulses.

4. The neurostimulation system of claim 2 , wherein the third set of stimulation pulses has a different amplitude than the second set of stimulation pulses.

5. The neurostimulation system of claim 2 , wherein the second and third sets of stimulation pulses are delivered in a sequence to define a stimulation pattern.

6. The neurostimulation system of claim 2 , wherein the awake titration includes determining a stimulation level operating window.

7. The neurostimulation system of claim 1 , wherein the microprocessor is programmed to perform at least one of the awake titration or the asleep titration in response to an input from a user.

8. The neurostimulation system of claim 7 , wherein the input defines at least one of the lower limit, the first upper limit, or the second upper limit.

9. The neurostimulation system of claim 1 , wherein the awake titration includes determining a stimulation level operating window.

10. The neurostimulation system of claim 1 , wherein the awake titration includes determining a stimulation level that causes muscle contraction.

11. The neurostimulation system of claim 1 , wherein the microprocessor is further programmed to, as part of the asleep titration, subsequently deliver a third set of stimulation pulses at a plurality of third stimulation setting values, wherein one or more of the plurality of third stimulation setting values is different than one or more of the plurality of second stimulation setting values.

12. The neurostimulation system of claim 1 , wherein the awake titration defines a stimulation level operating window having a capture stimulation level and a maximum comfort stimulation level inclusively between which the first set of stimulation pulses is delivered, the capture stimulation level corresponding to respiratory muscle movement, the maximum comfort stimulation level being greater than the capture stimulation level.

13. The neurostimulation system of claim 1 , wherein the second set of stimulation pulses are delivered at a magnitude that is greater than the maximum comfort stimulation level.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: LIVANOVA USA, INC.
Reel/Frame 057552/0378 →
SECURITY INTEREST Recorded Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: LIVANOVA USA, INC.
Reel/Frame 057189/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: LIVANOVA USA, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0784 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: LIVANOVA USA, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 053673/0675 →
CHANGE OF NAME Recorded Mar 10, 2020
From: CYBERONICS, INC.
To: LIVANOVA USA, INC.
Reel/Frame 052133/0771 →
Continuity (3)
Continuation 12650045 · Dec 30, 2009
Provisional Application 61204008 · Dec 31, 2008
Related Publication 20180008824A1 · Jan 11, 2018
Cited By (4)
US 12,262,988 US 12,539,418 US 12,589,250 US 12,599,329